2.390EUR0.00%Mkt Cap: 29.49M EURP/E: 23.90Last update: 2026-06-01
genOway Société anonyme, a biotechnology company, engages in the development and commercialization of custom genetically modified mouse, rat, and cell line models worldwide. It produces customized mouse models, such as k…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap29.49M EUR
Enterprise Value—
Revenue (TTM)20.96M EUR
Gross Profit10.25M EUR
Net Income (TTM)927.75K EUR
Revenue/Share—
Last Price2.390 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees—
CountryFR
SectorHealthcare
IndustryBiotechnology
ISINFR0004053510
Valuation
P/E (Trailing)23.90
P/E (Forward)15.93
PEG—
EV/EBITDA—
EV/Revenue—
P/S1.41
P/B1.30
EPS (TTM)0.10
EPS (Forward)0.15
52W Range
2.10021% of range3.500
52W High3.500 EUR
52W Low2.100 EUR
Profitability
Gross Margin48.90%
Oper. Margin19.61%
EBITDA Margin0.00%
Profit Margin4.43%
ROE3.71%
ROA2.05%
Growth
Revenue Growth-43.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.43M EUR
CapEx (TTM)10.93M EUR
FCF Margin—
FCF Yield—
Net Debt6.72M EUR
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.55
Current Ratio8.26
Quick Ratio5.68
Book Value/Sh1.832 EUR
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.12.34M
Float—
Insiders7.76%
Institutions15.86%
Technical
SMA 502.458 (-2.8%)
SMA 2002.585 (-7.5%)
Beta0.40
S&P 52W Chg27.94%
Avg Vol (30d)9.34K
Avg Vol (10d)4.43K
Technical Indicators
RSI (14)43.9
MACD-0.0147
MACD Signal-0.0082
MACD Hist.-0.0065
BB Upper2.528 EUR
BB Middle2.438 EUR
BB Lower2.348 EUR
BB Width7.41%
ATR (14)0.0725 EUR
Vol Ratio (20d)0.33x